AEON
AEON Biopharma, Inc.
stockNYSEAMERICAN
At CloseOct 9, 2026 3:59:30 PM EDT
0.28USD-9.677%(-0.03)1,627,968
Pre-marketOct 9, 2026 9:19:30 AM EDT
0.3005USD-3.065%(-0.0095)
After-hoursOct 9, 2026 4:55:30 PM EDT
0.2792USD-0.286%(-0.0008)
Loading…
Loading…
13.97M
Healthcare
Biotechnology
HQ
Newport Beach, CA, USA
Previous Close
$0.31
Beta
0.24
52-Week High
$1.45 2026-02-23
52-Week Low
$0.18 2026-08-20
SMA 50
$0.27
SMA 200
$0.74
Avg. Vol 10D
13.62M
Avg. Vol 30D
13.06M
Avg. Vol 90D
6.14M
Relative Vol
0.12
49.88M
12.10M
24.26%
2,171,628
17.94%
1.00
38%/62%
51.91%
36.00%
15.4000%
5,800,000
17,698
113,227
435,695
Nov 13, 2026 (33d)
Feb 26, 2025 · 1-for-72 (reverse)
Oct 9, 2026
Oct 5, 2026
AEON: Initiating Coverage – Imitation is a Sincere Form of Flattery: Seeking a Botox Biosimilar · 
Zacks Small Cap Research
Sep 30, 2026
AEON Profile
we are a nasdaq-listed special purpose acquisition company whose business purpose is to effect a merger or similar business combination with one or more businesses. our acquisition strategy is to identify and complete our initial business combination with a medical technology company in the healthcare industry. our sponsor team consists of chairman/ceo robert palmisano, president vikram malik, cfo oleg grodnensky and chief legal officer david meredith.
AEON Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.27 | 2026-10-05 | +3.70% | -5.466 |
| 1M | 0.33 | 2026-09-11 | -14.35% | 0.309 |
| 3M | 0.48 | 2026-07-10 | -42.04% | 2.464 |
| 6M | 0.84 | 2026-04-10 | -66.67% | 0.720 |
| 1Y | 1.13 | 2025-10-10 | -75.22% | 0.244 |
| 2Y | 71.71 | 2024-10-11 | -99.61% | — |
| 5Y | 662.40 | 2023-07-24 | -99.96% | 0.772 |
AEON Stock Summary
AEON Biopharma, Inc. (NYSEAMERICAN:AEON) stock price today is $0.28, and today's volume is 1,627,968. AEON is down 9.677% today. The 30 day average volume is 13.06M. AEON market cap is $13.97M with 49.88M shares outstanding.